delstrigo
merck sharp & dohme b.v. - doravirine, lamivudine, tenofovir disoproxil fumarate - hiv-infeksjoner - antivirale midler til behandling av hiv-infeksjoner, kombinasjoner - delstrigo er indisert for behandling av voksne smittet med hiv-1 uten tidligere eller nåværende bevis for motstand mot nnrti klasse, lamivudine, eller tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
pifeltro
merck sharp & dohme b.v. - doravirine - hiv-infeksjoner - antivirale midler til systemisk bruk - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
pifeltro 100 mg
abacus medicine a/s - doravirin - tablett, filmdrasjert - 100 mg
sandimmun neoral 25 mg
novartis norge (2) - ciklosporin - kapsel, myk - 25 mg
sandimmun neoral 50 mg
novartis norge (2) - ciklosporin - kapsel, myk - 50 mg
sandimmun neoral 100 mg
novartis norge (2) - ciklosporin - kapsel, myk - 100 mg
sandimmun neoral 100 mg/ ml
novartis norge (2) - ciklosporin - mikstur, oppløsning - 100 mg/ ml
sandimmun neoral 25 mg
farmagon - ciklosporin - kapsel, myk - 25 mg
sandimmun neoral 25 mg
farmagon - ciklosporin - kapsel, myk - 25 mg
sandimmun neoral 25 mg
farmagon - ciklosporin - kapsel, myk - 25 mg